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Transmissible spongiform encephalopathy strains can be differentiated by their behavior in bioassays and
by molecular analyses of the disease-associated prion protein (PrP) in a posttranslationally transformed
conformation (PrPSc). Until recently, isolates from cases of bovine spongiform encephalopathy (BSE) appeared
to be very homogeneous. However, a limited number of atypical BSE isolates have recently been identified upon
analyses of the disease-associated proteinase K (PK) resistance-associated moiety of PrPSc (PrPres), suggesting
the existence of at least two additional BSE PrPres variants. These are defined here as the H type and the L type,
according to the higher and lower positions of the nonglycosylated PrPres band in Western blots, respectively,
compared to the position of the band in classical BSE (C-type) isolates. These molecular PrPres variants, which
originated from six different European countries, were investigated together. In addition to the migration
properties and glycosylation profiles (glycoprofiles), the H- and L-type isolates exhibited enhanced PK sensi-
tivities at pH 8 compared to those of the C-type isolates. Moreover, H-type BSE isolates exhibited differences
in the binding of antibodies specific for N- and more C-terminal PrP regions and principally contained two
aglycosylated PrPres moieties which can both be glycosylated and which is thus indicative of the existence of two
PrPres populations or intermediate cleavage sites. These properties appear to be consistent within each BSE
type and independent of the geographical origin, suggesting the existence of different BSE strains in cattle. The
choice of three antibodies and the application of two pHs during the digestion of brain homogenates provide
practical and diverse tools for the discriminative detection of these three molecular BSE types and might assist
with the recognition of other variants.
Prion diseases, or transmissible spongiform encephalopa-
thies (TSEs), are a group of lethal and slow infectious diseases
that are unique by the involvement of an agent that contains a
host protein, the prion protein (PrP), in a posttranslationally
transformed conformation (PrPSc) and that does not seem to
contain any conventional form of nucleic acid (30, 46). PrP is
essential in disease development since without its presence no
infection has been shown to occur and during infection it
usually deposits as PrPSc in nervous system tissues, which re-
sults in a disease with fatal consequences (9, 13, 19, 47, 51).
PrPSc is partially resistant to proteinase K (PK), and the PK
resistance-associated moiety is defined by the term PrPres.
As in microbial infections, prion diseases are subject to
strain variations. In sheep and goats, in which scrapie has been
known to occur for centuries, transmissions to mice and other
experimental animals have revealed the occurrence of at least
20 different strain-dependent variations, including different
vacuolar lesion patterns in the brain, different disease incuba-
tion times, different molecular characteristics of PrPres, differ-
ent distributions of PrPSc in the brain, and different behavioral
patterns in infected animals (5, 6, 11, 12, 26, 33, 50, 56). It is
highly probable that the strain-dependent variations in PrPres
are due to conformational variations of PrPSc, which, notably,
determine the extent of degradation by PK (5, 6, 20, 43, 50, 55,
57).
Following the recognition of bovine spongiform encephalop-
athy (BSE) in cattle and the BSE epidemic in the United
Kingdom (59, 60), serious health concerns prevailed because of
the uncertainty about the potential risk of BSE to human
health when bovine materials were used for medical purposes
or served as food. A striking phenomenon in the BSE epidemic
was the homogeneity of the agent, leading to the conclusion
that only one strain of TSE was involved, as established in
experimental inbred mouse models (11, 29). These observa-
tions were further substantiated when transgenic mice express-
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ing either bovine or murine PrP in multiple copy numbers were
challenged with BSE and the strain characteristics in all the
mice were the same (15, 18, 52). However, the possibility of the
presence of a mixture of strains among BSE and scrapie iso-
lates has also been suggested (1, 2, 38).
More than 180,000 cases of BSE have been reported within
the United Kingdom by passive surveillance since the begin-
ning of the epidemic. In the European Union, since the year
2001, all slaughter cattle aged 30 months or older and all fallen
stock animals older than age 24 months must be rapidly tested
for BSE (24). This has led to the detection of over 5,000 BSE
cases outside the United Kingdom. On the basis of the results
available from diagnostic and limited bioassay studies, the
cases from this active surveillance are expected to be of the
same BSE type as the type detected in the United Kingdom
(16, 22, 37). However, rare variants of BSE have now also been
detected as a consequence of this active surveillance in cattle
(Bos taurus) (8, 14, 17, 23, 45, 49, 61) and in a miniature zebu
(Bos indicus) (53). The isolates from these cases showed by
Western blot (WB) analysis a PrPres profile that deviated from
that of the classical BSE cases (named the C type), in which the
PrPres bands migrated to a higher (H type) or a lower (L type)
position (8, 17). Both atypical forms, but especially the L type,
were further characterized by a smaller proportion of diglyco-
sylated PrPres compared to the proportion in C-type BSE iso-
lates. The histological features seen in the initial report of the
two L-type cases were peculiar because of the prominent in-
volvement of the forebrain; in contrast, in C-type BSE, the
brain stem is primarily affected. Moreover, PrPSc was depos-
ited in unusual amyloid plaques, which led to the name bovine
amyloidotic spongiform encephalopathy (17). Other reports
describing PrPres from cattle with atypical profiles have ap-
peared; these include both an L-type case and an H-type case
in Germany and single unclassified cases in each of Poland, the
United States, Japan, and Belgium (10, 14, 23, 45, 49, 61).
Recent reports have shown that such atypical H- and L-type
isolates are transmissible to mice and clearly differ from C-type
BSE isolates, with unique incubation periods, PrPres profiles,
and histological lesions (3, 4, 7, 14).
This study analyzed together 17 aberrant BSE isolates from
six European countries with the purpose of studying in depth
the behavior, comparability, and homogeneity of their molec-
ular properties by the use of WB analysis. All BSE isolates
could be differentiated into three groups, i.e., the L, C, or H
type, by using the previously published criteria of apparent
molecular mass and glycoprofile, while other criteria for their
discrimination were also defined, such as sensitivity to PK,
whether an additional nonglycosylated PrPres band was present,
and antibody-dependent molecular patterns.
MATERIALS AND METHODS
Animals and tissues. In this collaborative European network study of rumi-
nant TSE strains, 9 brain stem samples from C-type BSE cases and 17 brain stem
samples from atypical BSE cases from six different participating national refer-
ence laboratories were studied. Among the atypical samples, 6 were classified as
being of the H type and 11 were classified as being of the L type, on the basis of
their migration positions and the glycoprofile of PrPres, as published previously
(8, 17). Data on these cases are presented in Table 1 and include the PrPres
classification, the country of origin, the age and health status of the animal, and
the test used for the initial diagnosis. The tissues had been stored at 20°C or
lower.
Tissue treatments. Ten percent homogenates were prepared by homogeniza-
tion in lysis buffer consisting of 0.5% Triton X-100 and 0.5% sodium deoxy-
cholate in phosphate-buffered saline (138 mM NaCl, 2.7 mM KCl, 8 mM
Na2HPO4, 2.8 mM KH2PO4, pH 7.2). The homogenizations were performed for
45 s at 23,000 rpm in regular Prypcon vials with a MediFASTH homogenizer
(Consul AR SA; Villeneuve, Switzerland). Coarse sediment was removed by
centrifugation at 425  g for 5 min at ambient temperature. Usually, digestions
of 100 l of homogenates were performed with PK (30 U/mg; 124568; Merck,
Darmstadt, Germany) at 50 g/ml for 60 min at 37°C; and the reactions were
stopped by the successive addition of 10 l of a solution of 3-mg/ml Pefabloc
(Pefabloc SC; Roche, Almere, The Netherlands) in water and 100 l of 20%
(wt/vol) sucrose, 0.282 M Tris base, 0.212 M Tris-HCl, 4% (wt/vol) sodium
dodecyl sulfate (SDS), 1.0 mM EDTA, 0.038% (wt/vol) bromophenol blue, and
4% (vol/vol) -mercaptoethanol (2 sample buffer) with heating for 5 min at
95°C. For studies on the effect of pH, temperature, and enzyme concentration,
phosphate- and Tris-based buffers with pHs ranging from 6.5 to 8.0 were pre-
pared for adjustment of the pH during digestion with PK. The phosphate buffers
were prepared by titrating 200 mM KH2PO4 solution with 200 mM Na2HPO4
solution until the desired pH was reached. The Tris buffers were prepared by
titrating 200 mM Tris solution with 4 M HCl solution until the desired pH was
reached. An equal volume of pH adjustment buffer was added to 50 l of
homogenate to obtain the desired pH. After the addition of PK to the phosphate-
buffered saline in order to reach concentrations that varied from 5.6 g/ml to 450
g/ml, digestion was performed either for 40 min at 50°C or for 60 min at 37°C.
Before and after digestion with PK, the pH of the sample was measured with a
pH microelectrode (Biotrode; Hamilton). The reaction was stopped by the suc-
cessive addition of 10 l of 3 to 30 mg/ml Pefabloc and 100 l of 2 sample
buffer with heating for 5 min at 95°C. For a number of experiments, a precipi-
TABLE 1. BSE isolates used and their classificationa
PrPres type
and case no. Country
b Age
(yr) Health status
Initial
diagnostic
assayc
C type
NL5 NL 5 Clinical I
NL6 NL 6 Clinical I
NL15 NL 9 Clinical P
NL16 NL 6 Clinical P
NL17 NL 6 Clinical P
NL20 NL 5 Slaughter P
NL36 NL 8 Emergency P
288/02 IT 8 Downer P
R126/03 GE 13 Slaughter T
H type
NL22 NL 13 Slaughter P
03-0440 FR 15 Fallen stock P
03-1928 FR 8 Slaughter P
45 PL 10 Slaughter T
Mar-2006 SW 12 Fallen stock T
R152/04 GE 13 Slaughter T
L type
NL47 NL 9 Slaughter P
NL58 NL 12 Slaughter P
02-2528 FR 8 Fallen stock P
10-88 IT 15 Slaughter P
2 PL 13 Slaughter E
15 PL 9 Slaughter T
17 PL 13 Emergency T
28 PL 11 Slaughter T
31 PL 13 Fallen stock T
43 PL 12 Fallen stock T
R172/02 GE 15 Slaughter T
a For all samples brain stem tissue was used.
b NL, The Netherlands; IT, Italy; GE, Germany; FR, France; PL, Poland; SW,
Sweden.
c I, immunohistochemistry; P, Prionics Check WB assay; T, Bio-Rad TeSeE
enzyme-linked immunosorbent assay; E, Enfer enzyme-linked immunosorbent
assay.
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tation step was introduced after Pefabloc was added to remove tissue matrix
components and, eventually, to concentrate PrPres; the sample was mixed with
100 l of 1-propanol, vortexed, and centrifuged at 21,000  g for 5 min in a
microcentrifuge (5417R; Eppendorf) at room temperature. The pellet was dis-
solved in sample buffer (2 sample buffer diluted with an equal volume of water)
to the desired volume and heated. By dissolving the pellets in a volume smaller
than that used at the start, a concentration step of at least 10-fold was achieved.
Deglycosylation by treatment with PNGase F. Deglycosylation with 30 U of
peptide N-glycosidase F (PNGase F; New England Biolabs) was performed as
described previously (35).
SDS-PAGE, Western blotting, and immunochemical development. Ten micro-
liters of each sample was applied to each well for SDS-polyacrylamide gel
electrophoresis (PAGE). Electrophoresis was performed for 40 min at 200 V in
an XCell SureLock Mini-Cell gel electrophoresis system (Invitrogen, Breda, The
Netherlands) with either 10 or 17 wells precast to 1 mm with 12% Bis-Tris
NuPAGE gels and morpholinepropanesulfonic acid (MOPS) (or morpho-
lineethanesulfonic acid [MES]) running buffer with antioxidant. A mixture of the
commercially available markers MagicMark XP and SeeBlue Prestained (In-
vitrogen) was used as a reference for apparent molecular mass estimations. The
subsequent WB procedures (electrotransfer, immunostaining, and the develop-
ment of luminescence with CDP-Star as the substrate for alkaline phosphatase)
were performed as described previously (35). The results were recorded on
Hyperfilm ECL photographic film (Amersham, Buckinghamshire, United King-
dom), usually with exposure times of between 1 and 15 min. For quantification,
the films were digitized with a film scanner (ScanMaker III; Microtek). The
resulting image files were analyzed with quantitative software (Gel-Pro analyzer;
Media Cybernetics), and the integrated optical densities and apparent molecular
masses of the bands were exported to a spreadsheet for further calculation. For
calculation of the glycoprofiles for each lane, a baseline was set from the begin-
ning to the end of the peak profile, and the start and the end points of the peaks
were determined (overlapping peaks were split in the valley). Only the three
bands with molecular masses ranging from 30 to 16 kDa were used to calculate
the glycoprofile, for which each band was expressed as a percentage of the
summed integrated optical densities of the three bands in the triplet.
Antibodies and antibody binding specificities. The monoclonal antibodies
(MAbs) used in this study, all of which have suitable affinities for bovine PrP, have
the following epitope specificities, as mapped by Pepscan analysis (27, 35, 58): MAb
SAF32 is specific for the bovine PrP region 62/70/78/86QPHGGGW68/76/84/92 (25) and
was obtained from SPI-BIO (Montigny le Bretonneux, France); antibodies 12B2,
9A2, and L42 are specific for101WGQGG105, 110WNK112, and 156YEDRYY161,
respectively, and were described previously (31, 35); MAb 6H4 is specific for
156YEDRYYREN164 and was purchased from Prionics AG, Zu¨rich, Switzerland
(34); and MAb 94B4 (58) could be mapped to 198HTVTTTTK205.
Statistical analyses. One-way analyses of variance were carried out to establish
whether variations between groups of data were larger than expected; if so,
subsequent differences between pairs of groups were considered significant if the
probability of a nondifference was 0.05 in multiple-comparisons tests, accord-
ing to the Student-Newman-Keuls test. The software used for these calculations
was Instat Biostatistics from Graph-Pad Software, San Diego, CA.
RESULTS
Brain materials were studied after digestion with PK at 37°C
or 50°C in 10% homogenates and were subjected to SDS-
PAGE and WB analysis either directly or after a further treat-
ment with 1-propanol to concentrate PrPres while removing the
bulk of the tissue matrix components. All investigations were
focused on the molecular behavior of PrPres, determined by
using conventional WB techniques. Temperature had no pro-
found effect on the results. The alcohol treatment allowed
almost 100% recovery of PrPres from all isolates. This pretreat-
ment had no effect on the results obtained. Recently, we
showed that antibodies to PrP can be categorized into groups
A, B, and C, which are thought to bind in the bovine PrP
regions from positions 62 to 107, 109 to 164, and 154 to 236,
respectively (7). From these we selected for this study MAbs
SAF32 and 12B2 as representatives for group A; MAbs 9A2,
L42, and 6H4 as representatives for group B; and MAb 94B4
as a representative for group C.
Migration profile of atypical PrPres. Samples from con-
firmed BSE cases from France, Germany, Italy, Poland, Swe-
den, and The Netherlands were grouped into the C, H, or L
type according to the migration features observed in the par-
ticipating laboratories relative to the migration features of
C-type BSE isolates (Table 1). Indeed, the PrPres of the C-type
isolates showed a triplet of non-, mono-, and diglycosylated
bands; and a triplet banding pattern was also observed for the
H-type and L-type isolates, but they had different migration
positions when they were analyzed by using an antibody from
group B (Fig. 1A). The apparent molecular masses of the non-,
mono-, and diglycosylated bands of the H-type BSE isolates
were about 1.4 kDa greater than those of the C-type BSE
isolates (Fig. 1B). For L-type samples, the difference in the
migration of the diglycosylated PrPres band was especially pro-
nounced compared to the migration of the band for C-type
samples, running at a position 0.7 kDa lower (Fig. 1B), while
only a small difference of 0.3 kDa was observed for the non-
and monoglycosylated bands. An additional band of 7 kDa
was observed near the running front in all BSE types when
antibodies from group A or B were used for detection; how-
ever, for the H-type BSE isolates, this band was more promi-
nent (Fig. 1A, arrow).
Deglycosylation. Deglycosylation by PNGase F treatment of
L-, C-, and H-type BSE isolates resulted in the disappearance
of di- and monoglycosylated bands and an increase in the
nonglycosylated band when a group B-specific antibody was
used (Fig. 2). For each BSE type, after PNGase F treatment
the position of the nonglycosylated band was slightly higher
than that of the lowest band for untreated samples (compare
the lanes labeled  and  in Fig. 2). When the group C-
specific antibody was used, the H-type samples showed an
additional band at an apparent molecular mass of 10 kDa
before digestion with PNGase F (Fig. 2B, arrow); upon diges-
tion, this band had an increased signal and retained its migra-
FIG. 1. Results of WB analysis of L-, C-, and H-type BSE isolates
with group B antibody L42. (A) Lanes with L-, C-, and H-type material
with tissue equivalents of 0.5, 0.2, and 0.2 mg, respectively, placed
between molecular mass marker lanes; (B) apparent molecular masses
of diglycosylated (circles), monoglycosylated (squares), and nonglyco-
sylated (triangles) bands with standard deviations for L-type (n  11),
C-type (n  9), and H-type (n  6) isolates. Arrow, 7-kDa band.
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tion position. Depending on whether the running conditions
used MOPS or MES buffer for the SDS-PAGE Bis-Tris gels,
the nonglycosylated bands in particular migrated to different
relative mass positions, i.e., 10 and 12 kDa for the MOPS and
MES buffers, respectively (data not shown).
Resistance to PK digestion. The levels of resistance of the
isolates to PK were compared. At pHs above 7.0 or with in-
creasing PK concentrations (20 to 500 g/ml), the signal in-
tensities of the L and H types decreased, with no change in the
PrPres profile, although the C-type-related PrPres signal re-
mained rather stable. This was most evident when the digestion
was performed at two extreme conditions: mild (50 g/ml PK
and pH 6.5) or stringent (500 g/ml PK and pH 8.0) at 37°C
(Fig. 3A). Under mild conditions, the full-length PrP disap-
peared, while PrPSc was converted to PrPres in all individual
BSE isolates, irrespective of the antibody used. Under strin-
gent conditions, the signals of L- and H-type PrPress decreased
more rapidly, while that of the C-type PrPres stayed nearly at
the same level. The loss of signal between mild and stringent
conditions was less than 20% for the C-type isolates, while it
was more than 50% for both L- and H-type isolates (Fig. 3B).
Investigation of PrPres properties by using different PrP
N-terminus-specific antibodies. The differences in the molec-
ular masses of the PrPres bands between the BSE types were
further investigated with all samples and antibodies from
group A and B that bind very close to the region around the PK
cleavage site, that is, MAbs SAF32, 12B2, and 9A2. Core-
specific antibody 94B4 from group C was also used as a refer-
ence for the retention of the part of PrPSc conferring the most
PK resistance. This was tested with 50 g/ml PK at pH 6.5 or
500 g/ml PK at pH 8.0 (Fig. 4). After mild digestion at pH 6.5,
MAb SAF32, directed against the octarepeats of PrP, detected
only one fine band for H-type BSE in the region where the
diglycosylated PrPres migrates and no signal for C- or L-type
BSE. Antibody 12B2 bound to all bands of the PrPres triplet of
the H type but not at all or hardly at all to the PrPres bands of
the C type and not at all to the PrPres bands of the L type; MAb
9A2 detected the PrPres triplets of all BSE types.
Glycoprofiles. When the PrPres glycoprofiles were com-
pared, the L type was distinctly different from the C type due
to a lower proportion of the diglycosylated band, which was
about 40% of the total amount for the L type but about 60%
or more for the C type (Fig. 5). These data were further
confirmed by statistical analyses (see Materials and Methods).
The H type showed two different glycoprofiles, depending on
the antibody used for detection. With group B antibodies L42
and 6H4, the glycoprofile of the H-type samples was indistin-
FIG. 2. Deglycosylation effect of PNGase F on BSE types. Applied
tissue equivalents for L-, C- and H-type isolates: before deglycosyla-
tion, 0.4, 0.1, and 0.4 mg, respectively; after deglycosylation, 0.1, 0.025,
and 0.1 mg, respectively; respectively. (A) Blot development with
group B antibody 6H4; (B) blot development with group C antibody
94B4. The migration positions of molecular mass markers of 30 and 20
kDa are indicated by the bars on the left. The arrow points to the
10-kDa band, which appears in H-type BSE when the blot was devel-
oped with 94B4.
FIG. 3. Differentiation of L-, C- and H-type BSE isolates by sus-
ceptibility to PK digestion at 37°C under two conditions for pH and PK
concentration: pH 6.5 and PK 50 g/ml and pH 8.0 and PK 500 g/ml.
The tissue equivalent applied was 0.5 mg per lane. (A) Example of the
results obtained with antibody L42; (B) resistance to PK digestion
expressed as the integrated optical density ratio for the two digestion
conditions with L42 and 6H4 (group B antibodies) and 94B4 (group C
antibody).
1824 JACOBS ET AL. J. CLIN. MICROBIOL.
 at LAN
D
BO
UW
UNIVERSITEIT on Novem
ber 20, 2008 
jcm.asm.org
D
ow
nloaded from
 
guishable from that of the C-type samples and clearly different
from that of the L-type samples. With antibody 94B4, however,
the PrPres profile was intermediate between that of the C type
and the L type, which was due to a relatively lower percentage
of the diglycosylated band and a higher percentage of the
monoglycosylated band in the H type (Fig. 2 and Fig. 5A). In
comparison to the percentage of the diglycosylated PrPres
bands obtained with antibody L42, the use of antibody 6H4
resulted in a slightly higher percentage of the diglycosylated
PrPres bands for the C and the H types (Fig. 5B and C, respec-
tively).
In the supplemental material for this report, the results for
nearly all H-type and L-type cases from a single experiment are
presented together to display the homogeneity in the proper-
ties of PrPres, mentioned above, that discriminated them from
the C type.
DISCUSSION
Seventeen atypical BSE isolates were brought together for
an in-depth study of the molecular and biochemical properties
of PrPres, which represents the PK resistance-associated moi-
ety of PrPSc. These isolates originated from a geographical
region spanning a wide area in Europe and were designated
the L or the H type. Four isolates were already reported (8, 14,
17); and 13 additional isolates are described here for the first
time: 3 from The Netherlands, 7 from Poland, 2 from France,
and 1 from Sweden. The ages of the animals from which both
the H-type and the L-type isolates were recovered varied from
8 to 15 years. H- and L-type isolates displayed higher suscep-
tibilities to PK digestion than C-type BSE isolates, and also,
further discrimination procedures were unambiguous. For a
robust discrimination, five major criteria for PrPres were estab-
lished; and these five criteria (molecular mass, antibody bind-
ing affinity, digestion with PK at two conditions, glycoprofile
determination, and whether one or two PrPres populations are
present) can, in principle, be applied in a single WB analysis to
whole homogenates.
Determination of the molecular mass differences in the
FIG. 4. N-terminal truncation of PrPres and differentiation of H-
type BSE isolates from C- and L-type BSE isolates with antibody 12B2.
WBs of H-, C-, and L-type BSE isolates after PK digestion at 37°C with
50 g/ml PK and pH 6.5 and pH 8.0 are shown. The tissue equivalent
applied was 0.25 mg per lane. The gels were developed with group A
antibodies 12B2 and SAF32, group B antibody 9A2, and group C
antibody 94B4, as indicated.
FIG. 5. Glycoprofiles of PrPres from L-, C-, and H-type BSE iso-
lates. PK digestion was performed at 37°C with 50 g/ml PK at pH 6.5.
The tissue equivalent applied was 0.5 mg per lane. Development was
with group C antibody 94B4 (A) and group B antibodies L42 (B) and
6H4 (C). Symbols: squares, C type; circles, H type; triangles, L type.
VOL. 45, 2007 DISCRIMINATION OF BSE STRAINS 1825
 at LAN
D
BO
UW
UNIVERSITEIT on Novem
ber 20, 2008 
jcm.asm.org
D
ow
nloaded from
 
PrPres bands has been the first basis for the discrimination of
BSE types (8, 14, 17), but this needs some comment. C-type
BSE isolates have a PrPres migration pattern intermediate be-
tween those of the H and the L types. The differences in
apparent molecular masses between the C and the H types for
each of the three PrPres bands averages 1.3 kDa, as was also
noticed previously (8). However, the difference between the L
type and the C type is only 0.3 kDa for the nonglycosylated and
the monoglycosylated bands but about 0.8 kDa for the digly-
cosylated band. This was also evident from the report on the
German (14) and Italian (17) cases. In practice this molecular
mass discrimination, at least with only the nonglycosylated
band, is therefore considered unsuitable for the definite rec-
ognition of L-type cases.
With respect to the nonglycosylated moiety in the PrPres
triplet, H-type isolates again displayed a remarkable feature:
the presence of two nonglycosylated fragments, one at 19.1
kDa and the second one at about 10 kDa. However, the 10-
kDa band was detectable only with group C antibodies (with
MAbs 94B4 and SAF84 having the highest affinities), which
bind to PrP in the C-terminal region from positions 154 to 236
(7). If PNGase F was applied to PK-digested homogenates, the
increased concentrations of these two deglycosylated PrPres
bands indicate that both fragments are also present as glyco-
sylated moieties. However, depending on whether SDS-PAGE
in Bis-Tris gels used MOPS or MES buffer, the second non-
glycosylated band in particular migrated to different relative
mass positions, which were 10 and 12 kDa, respectively; and
this variation might be attributed to the influence of the pH in
the buffer on the physical behaviors of the peptides and on
their SDS binding capacities in this small mass range, although
the real effects involved are not fully understood. The appear-
ance of potentially two PrPres populations of 19.1 kDa and 10
kDa in a single isolate has also recently been found in C75BL/6
mice infected with H-type isolates, which is evidence for the
true strain-dependent nature of this molecular phenomenon
(7). The occurrence of a mixed PrPres population is rather
unique for TSE strains and suggests the existence of two PrPSc
populations which differ in their susceptibilities to PK diges-
tion and probably also in their conformation. Two PrPSc pop-
ulations could occur either in one or in two different co-
polymers. Alternatively, the phenomenon of two PrPres
populations could be the product of a single PrPSc conformer
unique to the H type with two differentially sensitive PK cleav-
age sites. It remains to be determined whether this is an in situ
phenomenon or whether it is caused by the PK treatment.
Another interesting aspect of the deglycosylation experiments
with PNGase F was the slightly slower rate of migration of the
deglycosylated band of each BSE type after treatment with
PNGase F compared to the rate for the nonglycosylated band
in untreated samples (compare the lanes labeled  and  in
Fig. 2). This phenomenon has already been described previ-
ously for PrPres derived from cattle and sheep with BSE (39,
58). While this difference in migration between the nonglyco-
sylated and deglycosylated bands is not yet fully resolved, it
might be a consequence of the formation of a negative charge
which occurs when PNGase F transforms asparagine into as-
partic acid during removal of N-linked carbohydrates. This
creates a negative repulsion, which results in fewer dodecyl
sulfate ions per protein molecule and, thus, in a lower net
negative charge load (21, 44).
Our data on the glycoprofiles of the three different BSE
types yield some further interesting information. A prominent
aspect in L-type isolates is the small proportion of diglycosyl-
PrPres, especially compared to that in C-type isolates and, to a
lesser degree, also compared to that in H-type isolates. In
C-type and H-type isolates, this fraction reaches values well
above 55%, while in L-type isolates it remains below 55%.
These differences were observed when detection antibodies
that bind to the core region of the PrP-like group A, antibodies
9A2, L42, and 6H4, were applied. For the H type, the glyco-
profile appeared, surprisingly, to depend also on the detection
antibody applied: while core-specific antibodies like L42, 6H4,
and 9A2 yielded features quite similar to those of C-type BSE
isolates, with group C antibody 94B4 the glycoprofile was in-
termediate between those of C- and L-type BSE isolates due to
the relatively large amount of staining in the position of the
monoglycosylated band (Fig. 5A). A plausible explanation for
this might be that C-terminus-specific antibodies like 94B4
react with two triple-banded PrPres populations, of which the
second population migrates to a position 5 to 10 kDa lower
than that where the first population migrates so that its digly-
cosylated band merges into the position of the monoglycosy-
lated band of the PrPres of the first population (7). In this
concept of two populations, group A and B antibodies like
12B2, 9A2, L42, and 6H4 can bind only to the first population;
group C antibodies bind to both populations. These data fur-
ther support the idea of the existence of a mixture of glycosyl-
ated PrPres populations, one of which is 1.3 kDa larger than
that of the C type and can be bound by N-terminus-, core-, and
C-terminus-specific antibodies, while the other is unusually
short and consists of the region from approximately positions
163 to 242 of PrP which can be bound only by group C anti-
bodies like 94B4 and SAF84. If PK cleaves near residue 163,
the occurrence of an 7-kDa band, such as that which is most
prominently present in H type, could represent a PrPSc frag-
ment that is located at the N terminus of this cleavage site (7).
A difference in the length of the PrPres molecules in H-type
isolates compared to the lengths in C- and L-type isolates was
also clearly confirmed by using group A antibody 12B2, which
binds to the N terminus of PrPres and which overtly detects
H-type BSE isolates. Interestingly, SAF32, whose epitope (the
octarepeat region) is more N-terminally located, also displays
a limited affinity for binding to H-type PrPres if digestion is
performed at pH 6.5, while group B antibody 9A2, in compar-
ison to 12B2, which binds only 9 amino acid residues farther
toward the C terminus of PrP does, fully binds to the PrPress of
all three types of BSE, which is very similar to the signal
obtained with antibodies like 94B4, L42, and 6H4. The epitope
data and grouping of these antibodies (see Materials and
Methods and Results) and the differences in the apparent
molecular masses of the PrPres types point to major cleavage
sites at approximately position 92 of bovine PrP for the H type,
position 103 for the C type, and position 108 for the L type
(Fig. 6).
Cleavage of PrPSc by endoproteases like PK hydrolyzes the
N terminus of PrPSc (6, 28, 32, 41, 42, 48). In C-type BSE
isolates and under the conditions used here (50 g PK/ml,
37°C, 10% brain homogenate in lysis buffer), this mainly occurs
1826 JACOBS ET AL. J. CLIN. MICROBIOL.
 at LAN
D
BO
UW
UNIVERSITEIT on Novem
ber 20, 2008 
jcm.asm.org
D
ow
nloaded from
 
up to residue 109 of bovine PrP and, thus, between the
epitopes of antibodies 12B2 and 9A2. This process, however,
also depends on the pH during the reaction, the enzyme/sub-
strate ratio, and also, possibly, the presence of denaturing
agents (36, 40). For the BSE isolates studied here, it became
clear that C-type BSE isolates are unusually resistant even
under the harshest conditions of pH 8.0 and an enzyme con-
centration of 500 g/ml. The H- and L-type isolates were more
susceptible; however, some residual PrPres always remained,
even under the most degradative conditions investigated. This
resistance to PK and other subtilisin-like enzymes like kera-
tinase has previously been noticed for scrapie isolate- and BSE
isolate-infected brain homogenates, where only denaturation
at temperatures well above 100°C allowed the full digestion of
detectable PrP (36). For diagnostic purposes, even if the di-
gestion conditions do not lead to a stable PrPres level, differ-
ences between BSE types can be reliably visualized by using
two different PK cleavage conditions at 37°C: pH 6.5 with 50
g PK/ml or pH 8.0 with 500 g PK/ml.
This study serves the important goal of defining adequate
tools for the discrimination of BSE types. Striking similarities
in molecular properties were encountered for the samples of
each BSE type when quite different treatments were applied
before analysis by WB. The main features are summarized in
Table 2. In practice, the following strategy for the determina-
tion of the BSE type (C, H, or L type) is proposed. A homog-
enate can be divided into two aliquots and titrated to obtain
two conditions of digestion with PK: mild and stringent. After
the PK digestion the digests are subjected to parallel electro-
phoresis and WB analysis with group A, B, and C antibodies
(MAbs 12B2, L42, and 94B4, respectively) at established anti-
body concentrations and with similar film exposures. Under
mild PK conditions, only the H type overtly binds to MAb 12B2
at an intensity similar to that at which it binds to MAbs L42
and 94B4. In the same blots, a stringent condition/mild condi-
tion signal ratio approximating 1 confirms the presence of the
C type, while a much lower value is found for the L and H
types. Simultaneously, the presence of the L type is confirmed
under mild digestion conditions by its special glycoprofile, with
approximately equal proportions of diglycosylated PrPres and
monoglycosylated PrPres, while the C type shows a clearly
higher proportion of the diglycosylated PrPres. The H-type
character is further confirmed by subjecting PK digests (at pH
6.5 to 7.4) to digestion with PNGase F, which leads to the
unique aspect of two deglycosylated PrPres bands when group
C antibody is used.
The increasing number of recognized atypical BSE cases
represents only a small fraction of the total BSE population.
FIG. 6. Approximate interpretation of major PK cleavage sites in PrPSc for the three types of bovine BSE in relation to the molecular masses
and the antibody specificities determined. The epitopes of the antibodies found to be reactive with the three different types of PrPres (the H, C,
and L types) and the apparent molecular masses determined by SDS-PAGE for the nonglycosylated moieties in each type are depicted. etc., PrPres
extends to the C terminus of mature PrP; black arrows, estimated major PK cleavage sites under standard conditions; vertical hatching, the residual
binding site of antibody SAF32 in the H type that remains if PrPSc is cleaved at a minor cleavage site (gray arrow); boPrP, bovine PrP. Antibody
P4 shows a high binding affinity if there is a serine at position 106, as in ovine and deer PrP, but not in bovine PrP; antibody 12B2 has a similarly
high affinity to the same N-terminal amino acids as P4 but is not dependent on positions 106 and 107. The second population of PrPres discussed
for H-type BSE isolates is not included in this illustration.
TABLE 2. Discrimination between BSE types on the basis of molecular properties of PrPres
BSE
type
Size differencea
(kDa)
Binding to
Ab 12B2
Glycoprofileb
(% diglyc)
No. of bands after
deglycosylation
with PNGase Fc
Proteolytic susceptibility
at pH 8/pH 6.5d
C Reference No 	50 1 	0.7
H 1.4 Yes Dual charactere 2 0.6
L 0.3 No 50 1 0.6
a Approximate difference from the value for the C type for the nonglycosylated band of the PrPres population in the 17- to 19-kDa region; the test was conducted
with group B antibody 9A2, L42, or 6H4.
b Percentage of diglycosylated (diglyc) fraction compared with that for the C type.
c Data represent results obtained with group C antibodies, like 94B4 and SAF84, which bind to the C-terminal domain at positions 163 to 242 of bovine PrP.
d See Fig. 3 for the method used to calculate the ratio.
e Depending on the use of antibodies of groups A and B or of group C (Fig. 5).
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This might well reflect an increased awareness, since the early
reports in 2004, of the existence of deviant phenotypes of BSE
in laboratories involved in the identification of BSE isolates. In
addition, this fraction occurs in older animals and might in-
crease due to the increased age of animals with BSE at the
time of detection as a result of the decrease in the level of the
BSE epidemic linked to contaminated meat and bone meal.
The high incidence of atypical cases in Poland might also have
a relation to the higher numbers of aged animals under sur-
veillance. Such cases, including C-type BSE, might also repre-
sent previously unnoticed sporadic forms of BSE. With this
study and recent publications (8, 14, 17), better awareness and
better possibilities for recognition are now available. Sporadic
forms of BSE are likely to exist, since even countries with low
levels of exposure or unlikely exposure to BSE, like Sweden,
Austria, the United States, Japan, and Canada, have detected
cases of BSE.
In routine BSE screening, atypical BSE cases (those of the H
type and the L type) can, in theory, be missed if the PrPres
signals are under the detection levels either due to the appli-
cation of PK digestion conditions that are too harsh or due to
the use of an unsuitable PrP N-terminus-specific antibody (L
type). However, it is unlikely that many of these atypical cases
have in fact been missed, since the isolates used in this study
were detected or their presence was confirmed by the most
frequently used commercial screening methods (Table 1). An-
other concern is the anatomical distribution of the PrPSc de-
position in the brain if it differs from that of C-type BSE, in
which the obex region is strongly involved in pathology and
which is used for routine diagnosis (54). A recent description
of an H-type isolate in a zebu showed that the distribution of
lesions was similar to that observed in typical BSE (53). In
contrast, the Italian L-type case studied here displayed only a
comparably weak signal in the obex region, while the thalamus
and olfactory bulb were the regions with the highest signals
(17). This concern is supported by the fact that it still cannot be
predicted whether these cases represent a risk to human health
(10). If one or both of the atypical BSE types leads to a human
health risk even higher than that presented by C-type BSE, it
would be crucial to be able to reliably detect such cases in the
bovine population and to differentiate them from C-type BSE.
These data, in any case, might contribute to our understand-
ing of the origin of the BSE epidemic, which remains unre-
solved and which is also a concern for the future. It is possible
that one of such atypical forms could have changed to C-type
BSE and was the origin of BSE. It is just as possible that they
could have coexisted with C-type BSE as sporadic forms while
the epidemic was disguising sporadic cases.
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